Sorafenib Plus TACE Versus Sorafenib Alone as Postoperative Adjuvant Treatment for Resectable Primary Advanced HCC
Clinical trial NCT04143191 · UNKNOWN
Trial details
- NCT number
- NCT04143191
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-15
- Primary completion
- 2021-09-15
- Enrollment
- 158
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.